Cure8 research brief
Frailty is linked to worse outcomes in older people with IBD, so knowing how common it is—and which patients are at higher risk—can influence monitoring and treatment planning.
If prevalence depends on the measurement tool, clinicians and patients should be aware that different assessments may identify different individuals as frail.
Older adults with IBD (≥60 years), gastroenterologists and IBD clinicians, geriatricians, and researchers studying frailty or outcomes in IBD.
This multicentre cohort study compared four common frailty scales (Fried Frailty Phenotype, FRAIL, Clinical Frailty Score, and SHARE-FI) in 612 IBD outpatients aged 60 and older and found that frailty prevalence varied substantially by tool (range ~4–17%).
Across scales, polypharmacy and higher comorbidity burden (CIRS-G ≥3) were consistently associated with frailty. The research highlights that different frailty measures capture different proportions of older IBD patients and that choice of scale affects prevalence estimates.
The study also identified other factors (older age, female sex, poor family support, longer IBD duration, and active disease) that were linked with frailty on most scales.
These findings suggest clinicians and researchers should be careful when selecting frailty instruments for older IBD populations and consider evaluating medication burden and comorbidity as part of geriatric assessment.
This brief is based on the article abstract provided in the journal record (structured content depth: abstract) and does not represent review of a full peer-reviewed manuscript beyond that abstract.
Structured content depth is abstract from the PubMed record; the curator note summarizes the study abstract rather than a full-text review. The study is observational and reports associations, not causation. Larger prospective work was recommended by the authors.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Diagnostic delays can mean a child with Crohn's disease doesn't get timely treatment. This report shows weight loss in young patients—especially girls—can be mistakenly labeled an eating disorder, so awareness and...
Noninfectious (aseptic) abscesses or persistent lymphadenitis can be an early extraintestinal sign of IBD in children. Recognizing this link can prompt appropriate imaging and endoscopic evaluation that may lead to...
The paper suggests that HRQoL and family functioning may be similar across disease types and common treatment approaches in children with IBD, but emotional health and parental worry remain areas needing attention.
